ישראל -
עברית -
Ministry of Health
אופטילסט
megapharm ltd - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.05 % - azelastine - azelastine - symptomatic treatment and prevention of seasonal allergic conjunctivitis.
ישראל -
עברית -
Ministry of Health
רינולסט
megapharm ltd - azelastine hydrochloride - תמיסה לאף - azelastine hydrochloride 0.1 %w/v - azelastine - azelastine - treatment of seasonal allergic rhinitis and perennial allergic rhinitis for adults and children 6 years and older.
ישראל -
עברית -
Ministry of Health
אזל-אבניר
bioavenir ltd, israel - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.5 mg / 1 ml - azelastine
ישראל -
עברית -
Ministry of Health
רינולסט
megapharm ltd - azelastine hydrochloride - תמיסה לאף - azelastine hydrochloride 0.1 %w/v - azelastine
ישראל -
עברית -
Ministry of Health
רינולסט
megapharm ltd - azelastine hydrochloride - תמיסה לאף - azelastine hydrochloride 0.1 %w/v - azelastine
ישראל -
עברית -
Ministry of Health
אזלסטין קומוד
kivema ltd - azelastine hydrochloride - טיפות עיניים - azelastine hydrochloride 0.05 %w/v - azelastine
ישראל -
עברית -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 200 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.
ישראל -
עברית -
Ministry of Health
קסאלקורי 250 מג
pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.